TotalMarketCap

Oragenics

OGENNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.553 M

$0.34 -7.50%

Close of 6 Nov 2026

As of 6 Nov 2026, Oragenics (OGEN) has a market capitalization of $1.55M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$984.2M

Loss-making

Shares outstanding

4,511,957

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #487GenprexGNPX$1.70M
  2. #488XORTX TherapeuticsXRTX$1.65M
  3. #489OragenicsOGEN$1.55M
  4. #490Kairos PharmaKAPA$1.55M
  5. #491Lakewood-Amedex BiotherapeuticsLABT$1.42M

What if Oragenics were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,258,234

Per share 18,187,253× higher

Bitcoin $1.53T

$338,622.13

Per share 984,081× higher

Apple $5.02T

$1,111,665

Per share 3,230,645× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for Oragenics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.